2Meier Y, Cavallaro M, Roos M, et al. Incidence of druginduced liver injury in medical inpatients [ J ]. Eur J Clin Pharmacol, 2005, 61 (2) : 135-143.
3A proposal of diagnostic criteria of drug-induced liver injury [ C ]//: Proceeding of the Third Drug and Liver Meeting. Tokyo: Toryo Printing Co., Ltd, 1978:96-98. (in Japanese).
4Standardization of definitions and criteria of causality assessment of adverse drug reactions. Drug-induced liver disorders: report of an international consensus meeting[ J]. Int J Clin Pharmacol Ther Toxicol, 1990, 28 (8): 317- 322.
5Danan G, Benichou C. Causality assessment of adverse reactions to drngs-I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries [ J ]. J Clin Epidemiol, 1993,46 ( 11 ) : 1323-1330.
6Maria VA, Victorino RM. Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis [J]. Hepatology, 1997, 26(3) :664-669.
7Iwasa M, Zeniya M, Kumagi T, et al. Modified diagnostic criteria of drug-induced liver injury proposed by the international consensus meeting [ J ]. Hepatogastroenterology, 2005, 52(63):869-874.
8Lucena MI, Camargo R, Andrade R J, et al. Comparison of two clinical scales for causality assessment in hepatotoxicity[ J ]. Hepatology, 2001,33 ( 1 ) :123-130.
9Fontana RJ, Watkins PB, Bonkovsky HL, et al. DrugInduced Liver Injury Network (DILIN) prospective study: rationale, design and conduct [J]. Drug Saf, 2009,32 ( 1 ) :55-68.
10Fontana ILl, Seeff LB, Andrade R J, et al. Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop [ J ]. Hepatology, 2010,52 ( 2 ) :730 -742.
